REGN US75886F1075

Report

Real-time Estimate Cboe BZX - 05/18 01:22:32 pm
668.51	USD		+0.14%

05/17	Vyriad, Inc. Raises $29.5M in Series B Funding Led by Renowned Genetics Entrepreneur	PR
05/16	Regeneron Pharmaceuticals, Inc. - HIGH SCHOOL SCIENTISTS FROM AROUND THE WORLD WIN NEARLY $8M IN AWARDS, SCHOLARSHIPS AT REGENERON INTERNATIONAL SCIENCE AND ENGINEERING FAIR	AQ
05/13	High School Scientists from Around the World Win Nearly $8M in Awards, Scholarships at Regeneron International Science and Engineering Fair	PR

Calendar

Event chart REGENERON PHARMACEUTICALS, INC.

Upcoming events on REGENERON PHARMACEUTICALS, INC.

06/01/22 \| 08:00am		Bernstein Strategic Decisions Conference
06/10/22 \| 10:30am		Annual General Meeting
06/14/22 \| 11:40am		Goldman Sachs Global Healthcare Conference
08/04/22		Interim 2022 Earnings Release (Projected)
11/08/22		Q3 2022 Earnings Release (Projected)
02/09/23		FY 2022 Earnings Release (Projected)
05/04/23		Q1 2023 Earnings Release (Projected)

Past events on REGENERON PHARMACEUTICALS, INC.

05/10/22 \| 04:20pm		Bank of America Healthcare Conference
05/04/22 \| 08:30am		Q1 2022 Earnings Call
05/04/22 \| 06:30am		Q1 2022 Earnings Release
03/16/22 \| 07:00am		Barclays Global Healthcare Conference
03/15/22 \| 09:00am		Oppenheimer Healthcare Conference
03/08/22 \| 01:30pm		Cowen & Co. Health Care Conference
02/28/22 \| 11:45am		American academy of allergy, asthma and immunology meeting - poster no : 571
02/28/22 \| 11:45am		American academy of allergy, asthma and immunology meeting - oral no : 633
02/27/22 \| 04:45pm		American academy of allergy, asthma, and immunology conference - oral no : 434
02/27/22 \| 11:45am		American academy of allergy, asthma, and immunology conference - poster no : 377

Past dividends on REGENERON PHARMACEUTICALS, INC.

- No events available -

Annual results

Fiscal Period : December		2017	2018	2019	2020	2021	2022
Sales M $	Released Forecast Spread	5 872 5 788 1,5%	6 711 6 520 2,9%	7 863 7 816 0,61%	8 497 8 494 0,04%	16 072 15 679 2,5%	11 844
Operating income (EBITDA) M $	Released Forecast Spread	2 732 2 658 2,8%	3 110 2 959 5,1%	3 420 3 610 -5,3%	4 245 4 158 2,1%	9 835 9 709 1,3%	5 944
Operating profit (EBIT) M $	Released Forecast Spread	2 080 2 094 -0,70%	2 534 2 424 4,5%	2 210 2 285 -3,3%	3 577 3 485 2,6%	8 947 9 040 -1,0%	4 899
Pre-Tax Profit (EBT) M $	Released Forecast Spread	2 079 2 075 0,16%	2 554 2 543 0,39%	2 429 2 308 5,3%	3 810 3 582 6,4%	9 326 9 442 -1,2%	4 968
Net income M $	Released Forecast Spread	1 199 1 438 -17%	2 444 2 257 8,3%	2 116 1 998 5,9%	3 513 3 160 11%	8 075 8 014 0,77%	4 040
EPS $	Released Forecast Spread	10,3 12,6 -18%	21,3 19,7 7,9%	18,5 17,6 4,7%	30,5 28,0 9,0%	72,0 71,1 1,2%	37,1
Announcement Date		02/08/2018	02/06/2019	02/06/2020	02/05/2021	02/04/2022	-

Quarterly results

Fiscal Period : December

2021 Q1

2021 Q2

2021 Q3

2021 Q4

2022 Q1

2022 Q2

Sales
M $

Released
Forecast
Spread

2 529
2 561
-1,3%

5 139
3 972
29%

3 453
2 800
23%

4 952
4 526
9,4%

2 965
2 690
10%

2 817

Operating income
(EBITDA)
M $

Released
Forecast
Spread

1 311
1 118
17%

3 564
2 813
27%

2 057
1 314
57%

2 903
2 564
13%

1 528
1 376
11%

1 303

Operating profit
(EBIT)
M $

Released
Forecast
Spread

1 113
1 040
7,0%

3 347
1 949
72%

1 847
1 278
45%

2 640
2 643
-0,13%

1 287
1 219
5,6%

1 222

Pre-Tax Profit
(EBT)
M $

Released
Forecast
Spread

1 253
1 079
16%

3 753
1 872
100%

1 817
1 392
30%

2 503
2 649
-5,5%

1 061
1 185
-10%

1 241

Net income
M $

Released
Forecast
Spread

1 115
953
17%

3 099
1 653
88%

1 632
1 152
42%

2 229
2 108
5,7%

974
1 038
-6,2%

923

EPS
$

Released
Forecast
Spread

10,1
8,31
21%

28,0
16,0
75%

14,3
10,7
34%

19,7
19,4
1,3%

8,61
8,77
-1,9%

9,06

Announcement Date

05/06/2021

08/05/2021

11/04/2021

02/04/2022

05/04/2022

Previous year

Next Year

Upcoming sector events for REGENERON PHARMACEUTICALS, INC.

07/27/22		VERTEX PHARMACEUTICALS INCORPORATED : Interim 2022 Earnings Release (Projected)
07/27/22		GILEAD SCIENCES, INC. : Interim 2022 Earnings Release (Projected)
08/08/22		BIONTECH SE : Interim 2022 Earnings Release
08/23/22		WUXI APPTEC CO., LTD. : Interim 2022 Earnings Release (Projected)
10/27/22		GILEAD SCIENCES, INC. : Q3 2022 Earnings Release (Projected)
11/02/22		VERTEX PHARMACEUTICALS INCORPORATED : Q3 2022 Earnings Release (Projected)
11/03/22		WUXI APPTEC CO., LTD. : Q3 2022 Earnings Release (Projected)
11/07/22		BIONTECH SE : Q3 2022 Earnings Release
02/01/23		VERTEX PHARMACEUTICALS INCORPORATED : FY 2022 Earnings Release (Projected)
02/07/23		GILEAD SCIENCES, INC. : FY 2022 Earnings Release (Projected)

More events

Past sector events for REGENERON PHARMACEUTICALS, INC.

05/09/22		BIONTECH SE : Q1 2022 Earnings Release
05/05/22 \| 04:01pm		VERTEX PHARMACEUTICALS INCORPORATED : Q1 2022 Earnings Release
04/28/22 \| 04:02pm		GILEAD SCIENCES, INC. : Q1 2022 Earnings Release
04/25/22 \| 05:52am		WUXI APPTEC CO., LTD. : Q1 2022 Earnings Release
03/30/22 \| 06:00am		BIONTECH SE : FY 2021 Earnings Release
03/23/22		WUXI APPTEC CO., LTD. : FY 2021 Earnings Release
02/01/22 \| 04:02pm		GILEAD SCIENCES, INC. : FY 2021 Earnings Release
01/26/22 \| 04:01pm		VERTEX PHARMACEUTICALS INCORPORATED : FY 2021 Earnings Release
11/09/21 \| 06:45am		BIONTECH SE : Q3 2021 Earnings Release
11/02/21 \| 03:01pm		VERTEX PHARMACEUTICALS INCORPORATED : Q3 2021 Earnings Release

More events

Analysis

Regeneron's COVID drug sales outside U.S. help revenue beat